Infliximab Treatment Along With Pegylated Interferon and Ribavirin in the Treatment of Hepatitis C
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate in subjects receiving their first course of
peg-interferon α-2b plus ribavirin therapy for chronic HCV infection